PMS2 and cancer: Table 3 describes the type and frequency of the different extracolonic tumors according to genotype. In addition, extracolonic cancers without a previous history of CRC were identified in 35%, 52% and 45% of individuals from families with path_MLH1, MSH2 and PMS2 variants, respectively.